Table 1.

Likelihood (χ²) for DR for CTS, OMm, OMclin1, OMclin2, and RS continuous prognostic scores in all patients and subgroups.

CTSOMmaOMclin1OMclin2OMm + CTS vs. CTSOMclin1 + CTS vs. CTSOMclin2 + CTS vs. CTSRSRS + CTS vs. CTS
Patients, nDR, nLR-χ²PLR-χ²PLR-χ²PLR-χ²PLR-Δχ²PLR-Δχ²PLR-Δχ²PLRχ²PLR-Δχ²P
All patients
0–10 years6468841.7<0.00125.4<0.00148.7<0.00145.0<0.00113.9<0.00115.8<0.00115.8<0.00118.8<0.00110.70.001
0–5 years64639 22.2<0.00112.6<0.00123.2<0.00120.0<0.001 6.30.0126.30.015.50.02
5–10 years57149 19.7<0.00112.8<0.00125.6<0.00125.1<0.001 7.50.0069.50.00210.40.001
Node-negative
0–10 years48250 23.3<0.00123.5<0.00131.3<0.00130.4<0.00112.0<0.00112.8 <0.00113.0<0.00115.0 <0.0017.00.008
0–5 years48221 14.9<0.00114.5<0.00119.3<0.00116.5<0.001 7.20.0077.80.0056.20.01
5–10 years43629 9.10.0039.50.00313.00.00114.2<0.0014.90.039.50.00210.40.001
Node-positive
0–10 years16438 5.60.023.20.076.00.024.30.042.30.132.40.132.10.153.50.062.90.09
0–5 years16418 2.40.120.70.421.30.270.80.37 0.30.580.20.670.150.70
5–10 years13520 3.20.072.80.095.30.034.00.05 2.40.122.90.092.60.11
  • Note: Likelihood ratio test based on Cox proportional hazard models for univariate and multivariate analyses. Comparisons with RS are presented for the 0–10 years time period only.

  • aOMm was available for 648 patients.